Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncology physicians' knowledge, attitudes, and practices regarding fertility preservation
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; McCabe, M. S.; Thom, B.; Jia, X.; Hudis, C.; Basch, E. M.; Kelvin, J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Gene expression profile testing for breast cancer: Patterns and predictors of use and impact on chemotherapy
    Meeting Abstract

    Hassett, M. J.; Niland, J. C.; Hughes, M. E.; Theriault, R. L.; Blayney, D. W.; Wong, Y.; Hudis, C.; Marcom, P. K.; Laronga, C.; Weeks, J. C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Meeting Abstract

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C. T.; Dickler, M. N.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Evaluation of the potential clinical utility of risk models incorporating genomic risk information
    Meeting Abstract

    Comen, E. A.; Balistreri, L.; Kirchhoff, T.; Gaudet, M.; Dutra-Clarke, A. V.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer
    Meeting Abstract

    Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Vornik, L.; Cornelison, T. L.; Hershman, D. L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene
    Meeting Abstract

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C.; Zeng, Z.; Viale, A.; Olshen, A.; Christensen, J. G.; Rosen, N.; Solit, D. B.; Weiser, M. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The development and implementation of an institution-based communication skills training program for oncologists
    Meeting Abstract

    Bialer, P. A.; Gilewski, T.; Kissane, D.; Levin, T.; Dickler, M. N.; Park, B. J.; Bylund, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • CALGB 40302: Fulvestrant with or without lapatinib as therapy for hormone receptor positive advanced breast cancer: A double-blinded, placebo-controlled, randomized phase III study
    Meeting Abstract

    Burstein, H. J.; Barry, W. T.; Cirrincione, C.; Chew, H. K.; Tolaney, S.; Lake, D.; Pluard, T.; Blackwell, K.; Winer, E. P.; Hudis, C. A.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Phase 1 dose-escalation study of the heat shock protein 90 inhibitor BIIB021 with trastuzumab in HER2+ metastatic breast cancer
    Meeting Abstract

    Modi, S.; Ismail-Khan, R.; Munster, P.; Lucas, M.; Galluppi, G. R.; Tangri, S.; Chen, Y.; Yamashita, M.; Storgard, C. M.; Moulder, S.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A dose-escalation study of trastuzumab-DM1 (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive, locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen
    Meeting Abstract

    Krop, I. E.; Modi, S.; Elias, A.; LoRusso, P.; Choi, Y. J.; Lu, M.
    Cancer Research (2010)

    Fulltext@MSK | Save